Original Article| Volume 36, ISSUE 1, P86-90, January 2022

The Association Between Institutional Mortality After Coronary Artery Bypass Grafting at One Year and Mortality Rates at 30 Days

Published:August 29, 2021DOI:


      To assess the association between the common quality metric of 30-day mortality and mortality at 60 days, 90 days, and one year after coronary artery bypass grafting.


      A retrospective cohort study, with multivariate logistic regression to assess association among mortality outcomes.


      Hospitals participating in Medicare and reporting data within the Centers for Medicare and Medicaid Services Limited Data Set between April 1, 2016, and March 31, 2017.


      A total of 37,036 patients undergoing surgery at 394 hospitals.



      Measurements and Main Results

      Mortality rates were 1.0%-to-3.1% for the top and bottom quartile of hospitals at 30 days. At one year, the top 25th percentile of hospitals had mortality rates averaging 3.9%; while hospitals below the 75th percentile had mortality rates averaging 7.6%. Twenty-three percent of hospitals in the top quartile at 30 days were no longer in the top quartile at 60 days. At one year, only 48% of hospitals that were in the top quartile at 30 days remained in the top quartile. The correlation between mortality rates at 30 days and the reported points was assessed using Spearman's rho. The R value between mortality at 30 days and mortality at one year was 0.53, which improved to 0.7 and 0.76 at 60 and 90 days.


      Mortality at 30 days correlated poorly with mortality at one year. Hospitals that were high- or low-performing at 30 days frequently were no longer within the same performance group at one year.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Benjamin EJ
        • Muntner P
        • Alonso A
        • et al.
        Heart disease and stroke statistics–2019 update: A report from the American Heart Association.
        Circulation. 2019; 139: e56-528
        • Fryar CD
        • Chen TC
        • Li X.
        Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010.
        NCHS Data Brief. 2012; : 1-8
        • Frojd V
        • Jeppsson A.
        Reexploration for bleeding and its association with mortality after cardiac surgery.
        Ann Thorac Surg. 2016; 102: 109-117
        • McIlvennan CK
        • Eapen ZJ
        • Allen LA.
        Hospital readmissions reduction program.
        Circulation. 2015; 131: 1796-1803
        • Bryant AS
        • Rudemiller K
        • Cerfolio RJ.
        The 30- versus 90-day operative mortality after pulmonary resection.
        Ann Thorac Surg. 2010; 89 (discussion 1722-13): 1717-1722
        • Siregar S
        • Groenwold RH
        • de Mol BA
        • et al.
        Evaluation of cardiac surgery mortality rates: 30-day mortality or longer follow-up?.
        Eur J Cardiothorac Surg. 2013; 44: 875-883
        • Hansen LS
        • Hjortdal VE
        • Andreasen JJ
        • et al.
        30-day mortality after coronary artery bypass grafting and valve surgery has greatly improved over the last decade, but the 1-year mortality remains constant.
        Ann Card Anaesth. 2015; 18: 138-142
        • Hua M
        • Scales DC
        • Cooper Z
        • et al.
        Impact of public reporting of 30-day mortality on timing of death after coronary artery bypass graft surgery.
        Anesthesiology. 2017; 127: 953-960
        • Hirji S
        • McGurk S
        • Kiehm S
        • et al.
        Utility of 90-day mortality vs 30-day mortality as a quality metric for transcatheter and surgical aortic valve replacement outcomes.
        JAMA Cardiol. 2020; 5: 156-165
        • Kurian D
        • Gorcos J
        • Meinke S
        • et al.
        Change management and an innovative approach to heart bypass surgery.
        Physician Exec. 2011; 37: 30-37
        • Hansen LS
        • Sloth E
        • Hjortdal VE
        • et al.
        Follow-up after cardiac surgery should be extended to at least 120 days when benchmarking cardiac surgery centers.
        J Cardiothorac Vasc Anesth. 2015; 29: 984-989
        • Adam MA
        • Turner MC
        • Sun Z
        • et al.
        The appropriateness of 30-day mortality as a quality metric in colorectal cancer surgery.
        Am J Surg. 2018; 215: 66-70
        • McMillan RR
        • Berger A
        • Sima CS
        • et al.
        Thirty-day mortality underestimates the risk of early death after major resections for thoracic malignancies.
        Ann Thorac Surg. 2014; 98 (discussion 1774-65): 1769-1774

      Linked Article

      • Outcome After Cardiac Surgery: The Devil Is in the Details
        Journal of Cardiothoracic and Vascular AnesthesiaVol. 36Issue 1
        • Preview
          Cardiac surgery entails sick patients undergoing major operations. Numerous preoperative, intraoperative, and postoperative factors profoundly influence outcome after cardiac surgery in complex ways (Table 1).1-5 Furthermore, cardiac surgery is associated with unique postoperative morbidities not found after noncardiac surgery, mostly from use of cardiopulmonary bypass (Table 1). Traditionally, mortality rates (usually at 30 days) for all surgical procedures (noncardiac and cardiac) have been used to evaluate numerous things: the procedure itself, surgeon, hospital, etc.
        • Full-Text
        • PDF